15.16MMarket Cap-109P/E (TTM)
4.8600High4.4600Low136.00KVolume4.7500Open4.6500Pre Close636.19KTurnover4.25%Turnover RatioLossP/E (Static)3.21MShares152.400052wk High1.26P/B15.12MFloat Cap1.800152wk Low--Dividend TTM3.20MShs Float1236.0000Historical High--Div YieldTTM8.60%Amplitude1.8000Historical Low4.6770Avg Price1Lot Size
Cingulate Stock Forum
📊⚡️📊
📊⚡️📊
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
Positive
Working capital increased by $19.5M from December 2023
Raised $12.5M in capital during Q3 2024
Net loss decreased by 46% YoY to $3.2M
R&D expenses reduced by $2.5M YoY
Secured European patents for CTx-1301 in up to 30 territories
Regained Nasdaq compliance with $1.00 minimum bid requirement
Negative
Accumulated deficit increa...
via @Lnova 👌
No comment yet